249 related articles for article (PubMed ID: 28231299)
1. Exploration of inhibitory mechanisms of curcumin in lung cancer metastasis using a miRNA- transcription factor-target gene network.
Jiao DM; Yan L; Wang LS; Hu HZ; Tang XL; Chen J; Wang J; Li Y; Chen QY
PLoS One; 2017; 12(2):e0172470. PubMed ID: 28231299
[TBL] [Abstract][Full Text] [Related]
2. Integrated microRNA and gene expression profiling reveals the crucial miRNAs in curcumin anti-lung cancer cell invasion.
Zhan JW; Jiao DM; Wang Y; Song J; Wu JH; Wu LJ; Chen QY; Ma SL
Thorac Cancer; 2017 Sep; 8(5):461-470. PubMed ID: 28660665
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive gene and microRNA expression profiling reveals miR-206 inhibits MET in lung cancer metastasis.
Chen QY; Jiao DM; Yan L; Wu YQ; Hu HZ; Song J; Yan J; Wu LJ; Xu LQ; Shi JG
Mol Biosyst; 2015 Aug; 11(8):2290-302. PubMed ID: 26075299
[TBL] [Abstract][Full Text] [Related]
4. Cytological effects of honokiol treatment and its potential mechanism of action in non-small cell lung cancer.
Zhang J; Zhang Y; Shen W; Fu R; Ding Z; Zhen Y; Wan Y
Biomed Pharmacother; 2019 Sep; 117():109058. PubMed ID: 31176168
[TBL] [Abstract][Full Text] [Related]
5. Curcumin exerts inhibitory effects on undifferentiated nasopharyngeal carcinoma by inhibiting the expression of miR-125a-5p.
Gao W; Chan JY; Wong TS
Clin Sci (Lond); 2014 Nov; 127(9):571-9. PubMed ID: 24896104
[TBL] [Abstract][Full Text] [Related]
6. Identification of lymph node metastasis-related microRNAs in lung adenocarcinoma and analysis of the underlying mechanisms using a bioinformatics approach.
Yan L; Jiao D; Hu H; Wang J; Tang X; Chen J; Chen Q
Exp Biol Med (Maywood); 2017 Apr; 242(7):709-717. PubMed ID: 28299977
[TBL] [Abstract][Full Text] [Related]
7. Identification of carcinogenic potential-associated molecular mechanisms in CD133(+) A549 cells based on microRNA profiles.
Chen QY; Jiao DM; Zhu Y; Hu H; Wang J; Tang X; Chen J; Yan L
Tumour Biol; 2016 Jan; 37(1):521-30. PubMed ID: 26227219
[TBL] [Abstract][Full Text] [Related]
8. Curcumin promotes apoptosis by activating the p53-miR-192-5p/215-XIAP pathway in non-small cell lung cancer.
Ye M; Zhang J; Zhang J; Miao Q; Yao L; Zhang J
Cancer Lett; 2015 Feb; 357(1):196-205. PubMed ID: 25444916
[TBL] [Abstract][Full Text] [Related]
9. Curcumin inhibits cell proliferation and induces apoptosis of human non-small cell lung cancer cells through the upregulation of miR-192-5p and suppression of PI3K/Akt signaling pathway.
Jin H; Qiao F; Wang Y; Xu Y; Shang Y
Oncol Rep; 2015 Nov; 34(5):2782-9. PubMed ID: 26351877
[TBL] [Abstract][Full Text] [Related]
10. Analysis of differential expression profile of miRNA in peripheral blood of patients with lung cancer.
He Q; Fang Y; Lu F; Pan J; Wang L; Gong W; Fei F; Cui J; Zhong J; Hu R; Liang M; Fang L; Wang H; Yu M; Zhang ZF
J Clin Lab Anal; 2019 Nov; 33(9):e23003. PubMed ID: 31541491
[TBL] [Abstract][Full Text] [Related]
11. Dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p) coordinately targeted MTDH in lung squamous cell carcinoma.
Mataki H; Seki N; Mizuno K; Nohata N; Kamikawaji K; Kumamoto T; Koshizuka K; Goto Y; Inoue H
Oncotarget; 2016 Nov; 7(44):72084-72098. PubMed ID: 27765924
[TBL] [Abstract][Full Text] [Related]
12. MiR-34c-3p suppresses the proliferation and invasion of non-small cell lung cancer (NSCLC) by inhibiting PAC1/MAPK pathway.
Zhou YL; Xu YJ; Qiao CW
Int J Clin Exp Pathol; 2015; 8(6):6312-22. PubMed ID: 26261507
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-139-5p inhibits cell proliferation and invasion by targeting insulin-like growth factor 1 receptor in human non-small cell lung cancer.
Xu W; Hang M; Yuan CY; Wu FL; Chen SB; Xue K
Int J Clin Exp Pathol; 2015; 8(4):3864-70. PubMed ID: 26097570
[TBL] [Abstract][Full Text] [Related]
14. The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis.
Li H; Xie S; Liu M; Chen Z; Liu X; Wang L; Li D; Zhou Y
Int J Oncol; 2014 Jul; 45(1):197-208. PubMed ID: 24805774
[TBL] [Abstract][Full Text] [Related]
15. Concordant dysregulation of miR-5p and miR-3p arms of the same precursor microRNA may be a mechanism in inducing cell proliferation and tumorigenesis: a lung cancer study.
Mitra R; Lin CC; Eischen CM; Bandyopadhyay S; Zhao Z
RNA; 2015 Jun; 21(6):1055-65. PubMed ID: 25852169
[TBL] [Abstract][Full Text] [Related]
16. Identification of key microRNAs associated with diffuse large B-cell lymphoma by analyzing serum microRNA expressions.
Meng Y; Quan L; Liu A
Gene; 2018 Feb; 642():205-211. PubMed ID: 29128636
[TBL] [Abstract][Full Text] [Related]
17. miR-126-3p and miR-451a correlate with clinicopathological features of lung adenocarcinoma: The underlying molecular mechanisms.
Chen Q; Hu H; Jiao D; Yan J; Xu W; Tang X; Chen J; Wang J
Oncol Rep; 2016 Aug; 36(2):909-17. PubMed ID: 27277197
[TBL] [Abstract][Full Text] [Related]
18. Construction of miRNA-mRNA-TF Regulatory Network for Diagnosis of Gastric Cancer.
Fu Z; Xu Y; Chen Y; Lv H; Chen G; Chen Y
Biomed Res Int; 2021; 2021():9121478. PubMed ID: 34840985
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of hsa-microRNA-204-5p and identification of its potential regulatory network in non-small cell lung cancer: RT-qPCR, bioinformatic- and meta-analyses.
Liang CY; Li ZY; Gan TQ; Fang YY; Gan BL; Chen WJ; Dang YW; Shi K; Feng ZB; Chen G
Respir Res; 2020 Feb; 21(1):60. PubMed ID: 32102656
[TBL] [Abstract][Full Text] [Related]
20. The microRNA expression signature of small cell lung cancer: tumor suppressors of miR-27a-5p and miR-34b-3p and their targeted oncogenes.
Mizuno K; Mataki H; Arai T; Okato A; Kamikawaji K; Kumamoto T; Hiraki T; Hatanaka K; Inoue H; Seki N
J Hum Genet; 2017 Jul; 62(7):671-678. PubMed ID: 28275243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
